Literature DB >> 27993799

Moving beyond sorafenib alone in advanced hepatocellular carcinoma: is hepatic arterial infusion chemotherapy the best option?

L Fornaro1, C Vivaldi1, G Lorenzoni1, G Masi1, I Bargellini1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 27993799     DOI： 10.1093/annonc/mdw664

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  3 in total

1.  miR-3609 Decelerates the Clearance of Sorafenib in Hepatocellular Carcinoma Cells by Targeting EPAS-1 and Reducing the Activation of the Pregnane X Receptor Pathway.

Authors:  Qing-Ping Shao; Chen Wei; Jie Yang; Wen-Zhou Zhang
Journal:  Onco Targets Ther       Date:  2020-07-27       Impact factor: 4.147

Review 2.  Implication of the Hedgehog pathway in hepatocellular carcinoma.

Authors:  Carminia Maria Della Corte; Giuseppe Viscardi; Federica Papaccio; Giovanna Esposito; Giulia Martini; Davide Ciardiello; Erika Martinelli; Fortunato Ciardiello; Floriana Morgillo
Journal:  World J Gastroenterol       Date:  2017-06-28       Impact factor: 5.742

Review 3.  Role of modern radiotherapy in managing patients with hepatocellular carcinoma.

Authors:  Liang-Cheng Chen; Hon-Yi Lin; Shih-Kai Hung; Wen-Yen Chiou; Moon-Sing Lee
Journal:  World J Gastroenterol       Date:  2021-05-28       Impact factor: 5.742
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.